Literature DB >> 34084028

Ocular cysticercosis at a teaching hospital in Northern India.

Rajendra P Maurya1, C P Mishra2, Meghna Roy1, Virendra P Singh1, Mahendra K Singh1, Mahima Yadav3, Abdullah S Al-Mujaini4.   

Abstract

BACKGROUND: Ocular cysticercosis (OC) is common in tropical countries. This study aimed to analyze the clinical presentation patterns, management and treatment outcomes of OC cases seen at a teaching hospital in North India.
METHODS: This study took place between March 2014 and February 2019. A total of 36 patients with OC were analyzed to determine clinical presentation and outcomes.
RESULTS: Of the 36 patients, 13 (36.11%) were male and 23 (63.89%) were female. The most frequently affected age group was 10-29 years (n = 22; 61.11%). All of the patients had unilateral lesions, with involvement of the left eye in 22 (61.11%) and the right in 14 (38.89%). The majority of cases were isolated to the ocular region; however, five (13.89%) demonstrated neural involvement as well. In terms of cyst location, 15 (41.67%) were orbital, 13 (36.11%) were subconjunctival and four each (11.11%) were intraocular or on the eyelid. The most common clinical presentations were subconjunctival masses or proptosis in 13 each (36.11%) and periorbital swelling in 12 (33.33%). Most patients received medical treatment (n - 23; 63.89%), while the others required surgical excision. Recurrence was noted in seven patients (19.44%), of which three underwent surgery while the rest were treated medically. Two patients (5.56%) developed phthisis.
CONCLUSIONS: In this study, OC cysts were more often orbital or subconjunctival compared to findings reported from Western countries. In addition, a female preponderance was noted in contrast to previously reported findings. Advanced radioimaging is crucial to ensure early diagnosis and treatment. Copyright:
© 2021 Oman Ophthalmic Society.

Entities:  

Keywords:  Albendazole; T.solium; ocular cysticercosis; orbital cysticercosis; scolex

Year:  2021        PMID: 34084028      PMCID: PMC8095313          DOI: 10.4103/ojo.OJO_122_2020

Source DB:  PubMed          Journal:  Oman J Ophthalmol        ISSN: 0974-620X


Introduction

Ocular cysticercosis is a disease caused by the parasitic infestation of the human eye by the Taenia solium species of pork tapeworm, resulting in the encystment of the ocular tissues.[12] Soemmering reported the first case of ocular cysticercosis in 1830, with the larvae responsible for the condition subsequently isolated during the extraction of the cyst from the anterior chamber.[3] Cysticercosis is endemic in tropical regions, including Southeast Asia, Sub-Saharan Africa, and Central and South America.[4] In India, the prevalence of cysticercosis is high, particularly in Uttar Pradesh, Andhra Pradesh, Odisha, and Punjab.[5678910] Predisposing factors include poor hygiene and sanitary conditions, contaminated pig-rearing conditions and drinking water, and eating undercooked pork and contaminated raw vegetables.[4] In general, T. solium larvae most commonly infect the nervous system, followed by the eyes, with ocular involvement accounting for 13%–46% of all systemic cases.[211] Clinical presentation depends on the location of the cyst.[4] In the eye, cysts may be located either intraocularly (i.e., in the vitreous body or subretinal space) or extraocularly (i.e., in the orbit, subconjunctival space, or on the eyelids). Intraocular cysts are especially harmful as they can lead to blindness due to severe inflammation.[4] In Western countries, cysts are most commonly observed in the posterior segment of the eye, while subconjunctival cysts are more frequent in India.[121314] Ocular cysticercosis is usually unilateral, with bilateral intraocular cysticercosis reported in only 5% of cases.[15] Disseminated cysticercosis with multiple organ involvement is also reported.[16] The early diagnosis of ocular cysticercosis is aided by clinical suspicion and B-scan ultrasonography or computed tomography (CT) of the orbit; such investigations also help to visualize the resolution of the cyst following treatment.[48] In some cases, an enzyme-linked immunosorbent assay (ELISA) may also be used to detect anticysticercus antibodies.[4] In general, treatment is conservative in the form of high doses of systemic oral steroids and anti-worm medication (i.e., albendazole).[48] The aim of this study was to describe the clinical presentation and treatment outcomes of cases of ocular cysticercosis seen at a teaching hospital in Northern India.

Materials and Methods

This hospital-based descriptive case series took place between March 2014 and April 2019 at the Regional Institute of Ophthalmology, Banaras Hindu University, Varanasi, Uttar Pradesh, India. A total of 36 consecutive patients diagnosed with ocular cysticercosis were followed up prospectively. Cases treated elsewhere and those who were lost to follow-up were excluded from the study. All patients were evaluated in an oculoplasty unit and underwent detailed history-taking, including for systemic illnesses, followed by a thorough physical and ocular examination. The latter included visual acuity tests and slit-lamp biomicroscopy, as well as a fundus examination of both eyes. Where appropriate, ancillary tests were also performed to determine the presence of diplopia and proptosis as well as ultrasonography A and B scans. Radiological investigations including CT scans and magnetic resonance imaging (MRI) of the brain and orbit were ordered to determine the extent and location of larvae infestation. Patients also underwent routine laboratory investigations, including a complete blood count, eosinophil count, and a stool examination to check for the presence of ova and larvae. A diagnosis of cysticercosis was supported by CT findings and positive serum cysticercosis antibodies via ELISA. In terms of treatment, all patients were initially prescribed albendazole tablets at a dose of 15 mg/kg daily and oral steroids at a dose of 1.5 mg/kg daily for 1 month. Subsequently, the systemic steroids were tapered gradually over the following 4 weeks. Patients who did not respond to medical treatment underwent surgical excision. Data concerning the patients' demographic characteristics, presenting symptoms and signs, cyst locations, and treatment outcomes were analyzed. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS), version 19.0 (IBM Corp., Armonk, New York, USA). Ethical approval for this study was obtained from the institutional ethical committee of Banaras Hindu University. All of the study procedures were performed in accordance with the revised Declaration of Helsinki. All patients provided written informed consent before being included in the study.

Results

Of the 36 patients with ocular cysticercosis, 13 (36.11%) were male and 23 (63.89%) were female, with a male-to-female ratio of 1:1.8. Patients ranged in age from 7 to 58 years, with the most frequent age group being 10–29 years (n = 22; 61.11%). The mean duration of symptoms was 5.40 months. All patients were affected unilaterally, with the left eye involved in 22 cases (61.11%) and the right eye in 14 (38.89%) [Table 1].
Table 1

Demographic and clinical characteristics of cases of ocular cysticercosis seen at a teaching hospital in northern India (n=36)

Characteristicsn (%)
GenderMale13 (36.11)
Female23 (63.89)
AgeRange in years7-58
Age group in years
1-94 (11.11)
10-1914 (38.89)
20-298 (22.2)
30-395 (13.89)
40-493 (8.33)
≥502 (5.56)
LateralityRight-sided14 (38.89)
Left-sided22 (61.11)
Location of cystEyelid4 (11.11)
Subconjunctival13 (36.11)
Orbital15 (41.67)
Intraocular4 (11.11)
Clinical presentationReduced vision6 (16.67)
Diplopia4 (11.11)
Proptosis13 (36.11)
Swelling12 (33.33)
Subconjunctival mass13 (36.11)
Other7 (19.44)
TreatmentSurgical excision13 (36.11)
Medical treatment23 (63.89)
OutcomeCured27 (75.00)
Recurrence7 (19.44)
Loss of vision/phthisis2 (5.56)
Demographic and clinical characteristics of cases of ocular cysticercosis seen at a teaching hospital in northern India (n=36) The majority of ocular cysticercosis cases were isolated (n = 31; 86.11%); however, five cases (13.89%) demonstrated simultaneous involvement of the brain. The location of the ocular cysts were orbital in 15 cases (41.67%) [Figures 1 and 2], subconjunctival in 13 (36.11%) [Figures 3 and 4], intraocular in four (11.1%), and on the eyelid in four (11.11%). The most common clinical presentation was a subconjunctival mass (n = 13; 36.11%) and proptosis (n = 13; 36.11%), followed by periorbital swelling (n = 12; 33.33%), diminished visual acuity (n = 6; 16.67%), and diplopia (n = 4; 11.11%) [Table 1].
Figure 1

(a) Photograph showing diffuse right infraorbital swelling and hyperglobus. (b) Axial computed tomography showing a well-encapsulated, nonenhancing cystic lesion with a hyperdense scolex in the right orbit. (c and d) Posttreatment photograph and axial computed tomography showing complete resolution

Figure 2

(a) Photograph showing diffuse left superomedial orbital swelling and nonaxial proptosis. (b) magnetic resonance imaging showing a well-defined ring-enhancing cystic lesion in the extraconal compartment of the superomedial left orbit with inflammatory changes involving the adjacent orbital fat. (c and d) Photographs showing transcutaneous excision of the cyst and the excised cyst wall alongside the pearly-white gelatinous scolex

Figure 3

(a and b) Photographs showing a right subconjunctival cyst. (c) Coronal computed tomography showing an eccentric, hyperdense, nodular scolex involving the lateral rectus muscle. (d and e) Photographs showing excision of the cyst and the excised cyst wall alongside the pearly-white gelatinous scolex. (f) Photomicrograph showing the cyst wall and larval branching body cavity and protoscolex

Figure 4

(a) Photograph showing a left subconjunctival cyst in the caruncular area. (b) magnetic resonance imaging showing features of cysticercosis. (c) Posttreatment photograph showing complete regression of the cyst

(a) Photograph showing diffuse right infraorbital swelling and hyperglobus. (b) Axial computed tomography showing a well-encapsulated, nonenhancing cystic lesion with a hyperdense scolex in the right orbit. (c and d) Posttreatment photograph and axial computed tomography showing complete resolution (a) Photograph showing diffuse left superomedial orbital swelling and nonaxial proptosis. (b) magnetic resonance imaging showing a well-defined ring-enhancing cystic lesion in the extraconal compartment of the superomedial left orbit with inflammatory changes involving the adjacent orbital fat. (c and d) Photographs showing transcutaneous excision of the cyst and the excised cyst wall alongside the pearly-white gelatinous scolex (a and b) Photographs showing a right subconjunctival cyst. (c) Coronal computed tomography showing an eccentric, hyperdense, nodular scolex involving the lateral rectus muscle. (d and e) Photographs showing excision of the cyst and the excised cyst wall alongside the pearly-white gelatinous scolex. (f) Photomicrograph showing the cyst wall and larval branching body cavity and protoscolex (a) Photograph showing a left subconjunctival cyst in the caruncular area. (b) magnetic resonance imaging showing features of cysticercosis. (c) Posttreatment photograph showing complete regression of the cyst Ultrasonography B was performed for 22 patients (61.11%) and revealed the presence of a hyperechoic area (i. e., the scolex of the tapeworm) within a well-demarcated clear cyst-like lesion. All of the patients underwent CT imaging, which demonstrated typical cysts in twenty patients (55.56%). In addition, 20 patients (55.56%) were tested for the presence of serum antibodies, of which 12 (60%) were positive. Examination of the stool for ova and larvae was positive in 15 cases (41.67%). Most patients (n = 23; 63.89%) were managed through medical treatment, while 13 (36.11%) required surgical excision. Patients were followed up for between three months and two years to check for recurrence. Overall, lesion recurrence was observed in seven patients (19.44%), of which three underwent surgery and the remaining four were treated medically. Two patients (5.55%) with intraocular cysticercosis developed phthisis [Table 1].

Discussion

Overall, approximately 50 million people worldwide are estimated to be affected by cysticercosis.[4] In India, the reported prevalence of cysticercosis is 1.41%–4.51%.[17] The clinicoepidemiological profile of ocular cysticercosis varies in different countries depending on geographical location, socioeconomic status, environmental conditions, sanitary and personal hygiene practices, and dietary habits.[418] In the present study, there was a predominance of female patients, with a male-to-female ratio of 1:1.8. In contrast, most previous studies report no gender predilection, although some have reported a male predominance.[121314192021] Infection mostly occurs among younger individuals, although individuals of any age may be affected. In the current study, the majority of patients (n = 26; 72.22%) were <30 years of age, with 14 (38.89%) being between 10 and 19 years old. These findings are similar to those observed in other case series.[1922] Reddy et al. reported that nine out of ten patients were younger than 15 years.[9] However, Madigubba et al. observed that patients with intraocular cysticercosis usually present at a more advanced age.[23] While ocular cysticercosis usually involves one eye, both eyes may be involved in cases of disseminated disease.[1516] In the present study, no cases of bilateral involvement were noted; however, there was a greater frequency of left-sided compared to right-sided lesions. One possible explanation for this might be due to the fact that the left internal carotid artery arises directly from the aorta, thus allowing the larvae to travel directly to the left eye, with the course of the ophthalmic artery encouraging the development of the cyst on the nasal side of the orbit or in the subconjunctival region. Any part of the eye can be affected by ocular cysticercosis. In Western countries, ocular cysticercosis cases are most commonly intraocular (i.e., in the vitreous body or retina), whereas cysts are more often orbital or subconjunctival among patients from the Indian subcontinent.[141523] In the current study, orbital cysts were most common (n = 15; 41.67%), followed by subconjunctival cysts (n = 13; 36.11%). Rath et al. reported the anterior orbit to be the most common location of ocular cysts (69%).[24] In another study, Kruger-Leite et al. reported that 35.0% of cysts were found in the subretinal space, 22.0% in the vitreous cavity, 22.0% were subconjunctival, and only 1.0% were orbital.[25] Table 2 highlights the differences in the location of ocular cysts in various case series.[91012131819202326]
Table 2

Literature review of cyst locations in ocular cysticercosis case series

Author and year of seriesTotal number of casesLocation of cysts, n (%)
SubconjunctivalIntraocularOrbitalEyelid
Reddy et al.9 (1964)106 (60)2 (20)1 (10)10 (10)
Sen et al.10 (1967)119 (81.82)2 (18.18)0 (0)0 (0)
Malik et al.19 (1968)1410 (71.43)1 (7.14)3 (21.43)0 (0)
Rao et al.26 (1967)1513 (86.67)1 (7.14)1 (7.14)0 (0)
Atul et al.18 (1995)331 (3.03)26 (78.79)6 (18.18)0 (0)
David et al.12 (2000)2511 (44)6 (24)6 (24)2 (8)
Madigubba et al.23 (2007)11874 (62.71)31 (26.27)8 (6.78)5 (4.24)
Lesh Jr.20 (1949)1157 (6.09)107 (93.04)1 (0.87)0 (0)
Welsh et al.13 (1987)131 (7.69)12 (92.31)0 (0)0 (0)
Present study (2020)3613 (36.11)4 (11.11)15 (41.67)4 (11.11)
Literature review of cyst locations in ocular cysticercosis case series The most common clinical presentations of ocular cysts in the present study were proptosis and subconjunctival masses (36.11% each). Diplopia was also noticed in 11.11% of cases. Two patients with eyelid cysts presented with abscesses. Those with subconjunctival cysticercosis usually presented with painful or painless hyperemic epibulbar masses, whereas 16.67% of patients had reduced vision, likely due to either optic nerve compression or involvement of the vitreous body and retina. Advanced radioimaging studies, such as ultrasonography, CT, and MRI scans, are crucial in diagnosing ocular cysticercosis.[4] In particular, ultrasound B scans are of great help in diagnosing lesions with hazy media in the intraocular regions and show a well-defined cyst filled with fluid or calcified nodules.[427] In addition, a CT scan of the orbit is a useful diagnostic tool to determine the presence of orbital cysts. Usually, CT scans reveal a hypodense mass with central hyperdensity suggestive of the scolex of the tapeworm.[4] Overall, 23 patients (63.89%) in the current study responded to medical treatment, with only 13 nonresponders (36.11%) requiring surgical excision. Cysticidal drugs were administered only after ruling out intraocular involvement, as dying cysticercus can release toxins which can cause a severe inflammatory reaction leading to blindness.[4] Albendazole and praziquantel are the most commonly recommended cysticidal drugs. Adnexal cysts are best treated by a combination of oral albendazole (15 mg/kg/day) and oral steroids (1.5 mg/kg/day) in tapering doses for 4–6 weeks, with oral steroids recommended to control any inflammatory reactions caused by dying cysticercus.[422] del Brutto and Sotelo found albendazole to be more effective and less expensive than praziquantel.[28] Current guidelines for treating cysticercosis recommend albendazole, with a reported cure rate of 60%–85%.[4] However, surgical removal with a pars plana vitrectomy should be considered in cases of intravitreal cysticercosis. Surgical excision of orbital cysts may cause postoperative fibrosis leading to restrictive ocular motility.[29] The limitations of this study include its relatively small sample size for the purposes of internal subgroup comparison and the attrition rate during follow-up. Nevertheless, this study provides important data regarding patterns of clinical presentation and disease management in North India.

Conclusion

Despite being a preventable cause of blindness, ocular cysticercosis is a common parasitical infestation in tropical countries such as India. The present study found that the majority of ocular cysticercosis cases were orbital, followed by subconjunctival, in contrast to previously reported findings from Western countries. Radioimaging and ELISA analysis for anticysticercal antibodies are important tools to ensure early diagnosis and timely treatment.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  20 in total

1.  OCULAR CYSTICERCOSIS.

Authors:  P S REDDY; O M SATYENDRAN
Journal:  Am J Ophthalmol       Date:  1964-04       Impact factor: 5.258

2.  Ocular cysticercosis.

Authors: 
Journal:  Am J Ophthalmol       Date:  1949-04       Impact factor: 5.258

3.  Ocular cysticercosis. A report of 13 cases.

Authors:  N H Welsh; A L Peters; W Crewe-Brown; P Blignaut; P Donnoli; B S da Souza; Y Javary
Journal:  S Afr Med J       Date:  1987-06-06

4.  Ocular cysticercosis.

Authors:  S R Malik; A K Gupta; S Choudhry
Journal:  Am J Ophthalmol       Date:  1968-12       Impact factor: 5.258

5.  A serological study of human cysticercosis in Pondicherry, South India.

Authors:  S C Parija; P S Sahu
Journal:  J Commun Dis       Date:  2003-12

6.  Ultrasonological characteristics of extraocular cysticercosis.

Authors:  Santosh G. Honavar; Chandra G Sekhar
Journal:  Orbit       Date:  1998-12

Review 7.  Human cysticercosis and Indian scenario: a review.

Authors:  Kashi Nath Prasad; Amit Prasad; Avantika Verma; Aloukick Kumar Singh
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

8.  Orbital cysticercosis: clinical manifestations, diagnosis, management, and outcome.

Authors:  Suryasnata Rath; Santosh G Honavar; Milind Naik; Raj Anand; Bhartendu Agarwal; Sannapaneni Krishnaiah; G Chandra Sekhar
Journal:  Ophthalmology       Date:  2010-01-08       Impact factor: 12.079

9.  Cysticercosis in South India.

Authors:  A J Veliath; C Ratnakar; L C Thakur
Journal:  J Trop Med Hyg       Date:  1985-02

10.  Intraocular cysticercosis.

Authors:  E Kruger-Leite; A E Jalkh; H Quiroz; C L Schepens
Journal:  Am J Ophthalmol       Date:  1985-03-15       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.